It was reported that a patient underwent an atrial fibrillation (afib) ablation procedure with a thermocool® smart touch® sf uni-directional navigation catheter for which biosense webster¿s product analysis lab (pal) identified a hole on the pebax.It was initially reported by the customer that during the operation, error code '319' was displayed.Additionally, a picture provided by the customer demonstrated a ¿401¿ error code.A second device was used to complete the operation.There was no adverse event reported on patient.The customer¿s reported noise and sensor errors are not considered to be mdr reportable since the potential risk that these could cause or contribute to a serious injury or death is remote.On 3-aug-2023, the bwi pal revealed that a visual inspection of the returned device found a hole with reddish material in the pebax area.These findings were reviewed and reassessed the issue of a ¿hole¿ in the pebax as an mdr reportable malfunction.
|
Device evaluation details: the device was returned to biosense webster inc (bwi) for evaluation and the evaluation has been completed.A visual inspection, an electrical test, and magnetic sensor functionality test of the returned device were performed following bwi procedures.Visual analysis revealed a hole with reddish material in the pebax area.No other damage was observed.The device was connected to the carto 3 system and it was recognized and visualized correctly.No issues or errors were observed.A picture was received from the customer where noise was observed; however, an electrical test was performed, and no electrical issues were found.The reddish material found could be related to the issues reported in the event.A manufacturing record evaluation was performed for the finished device, and no internal action related to the reported complaint condition were identified.The issue reported by the customer was confirmed.It should be noted that product failure is multifactorial.As part of biosense webster¿s quality process, all devices are manufactured, inspected, and released to approved specifications.E1.Initial reporter phone: (b)(6).If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
|